Travelers DRN (TRVC34Q) Quote

The easiest way the make money is selling shares. Just like the rest of the otc

CRISPR-X is working on CRISPR-associated transposases, base editors, prime editors, epigenetic editors and novel editing. All have (multiple) advantages over oligonucleotides.

No I am thinking the deal is done. No need to attract BP anymore. 😁😁

We can take a vote about how many people have been deceived by management on phone .

It’s because they don't want the clinicians and angry shareholders to be swarming their booth asking tough questions around regulatory status in the UK.

https://www.masters.com/en_US/fantasy/index.html

Lol. Revenue from UK in the first year will be less than $15M. Such a blockbuster drug!

So you admit LP must go if she dilutes shareholders at depressed valuation post UK approval given the blockbuster drug she holds? No excuses allowed, OK?

It looks like you don't ex

New IOV-5001 preclinical data to be presented late this month https://www.abstractsonline.com/pp8/#!/20273/presentation/8324

(OT) New data from the US NCI testing TIL (+/- anti-PD-1) https://www.nih.gov/news-events/news-releases/combination-immunotherapy-shrank-variety-metastatic-gastrointestinal-cancers

https://pbs.twimg.com/media/GndNWh8XYAAtBPs?format=jpg&name=large

The poor house?
Where did all the pump tards go? Those dumbasses actually believed what JK told them, and what they told each other.

What a lol.

Are we still doing the pancake thingy here?

Is U-sell-o still running this scam?

Would be nice if we got news of a deal with a big company name soon and the expectation of substantial revenue.

Whoaaaaa,  trouble ahead
https://vt.tiktok.com/ZSrhfF78o/

“The Division of Enforcement ("the Division") is submitting this status report to inform the Commission that it plans to file a Motion for Summary Disposition in this matter on or before June 30, 2025.”

lj: We'll see what happens today (Wednesday), so-called "Liberation Day".
Back at the ranch, counties in Maryland that have a relatively high population of Federal employees are going to see a significant decrease in County income tax (which are "piggybacked onto the State personal income ta

And you expected Trump to be gracious? Really?

I am wondering why Nwbo has been participating ASCO over 10 years, but they don't do it again at 2025. Even though the biggest news " Approval in UK" anytime.  In fact LP has to tell this amazing news to the world through the ASCO to attract BPs to come and acquire nwbo. Why LP don't need this year.

That's great!

In haematological malignancies, they are at the final dose level (flat dose of 4 billion).

https://pbs.twimg.com/media/GBFaKMcaYAAE8CV?format=jpg&name=large
https://pbs.twimg.com/media/GBFaKMdaoAEFw2z?format=jpg&name=large

Also, have been working on a single (CI

Will we get news of income this year or in 2027
Poloriton in djknows post keeps saying 2027!!!??
that is far off ,or are they talking about future product.even co says 2026 2027
We need income today, Commercialization was to begin 2024 ????

No Nasdaq, No New Buyers

90% of Reddit users: "I can't buy in! Elite is still on the OTC and my brokerage won't allow it!"

Institutional investors: "Why won't Elite uplist so we can buy in? What are they waiting for!!!???"

It will take an increas

Which is why I LAUGH any anyone who takes what he says seriously in the conference calls.

Famous quote: "There's a sucker born every minute!"

Nasrat has mentioned the Nasdaq and getting fundamentals in place since 2017.

Huh?

The next needle mover was ALREADY filed last year.

Question: "When do you anticipate filing the third needle mover product, assuming trial time line goes according to plan?"

Nasrat: "Next year, 2024 will be the time."

Conclusion:

I also think Nasrat traveled to India so he could have a FREE vacation on Elite's dime pretending as if it was a business trip.

I also think Nasrat traveled to India so he could see their labs, equipment, and cleaning processes first hand.